Similarly, down-regulation of miR-146a promoted AML disease progression by TRAF6-mediated induction of NF-κB [93] and miR-142 promoted the development of lymphoid and myeloid leukemia and was found recurrently mutated in AML [94]. This evidence concerns the gene TRAF6 and acute myeloid leukemia.